Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Introduction: The Coronavirus disease-2019 (COVID-19) pandemic that started over two years ago has led to high mortality and morbidity. Vaccine studies have been initiated worldwide to end the pandemic, and the CoronaVac® vaccine was first administered to healthcare workers at high risk of COVID-19...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Jezik: | Turkish |
Izdano: |
Galenos Yayinevi
2022-05-01
|
Serija: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
Teme: | |
Online dostop: | http://mjima.org/text.php?&id=322 |